Danne C, Entenza JM, Mallet A, Briandet R, D barbouill M, Nato F, Glaser P, Jouvion G, Moreillon P, Trieu-Cuot P, Dramsi S. Molecular characterization of a Streptococcus gallolyticus genomic island encoding a pilus involved in endocarditis. J Infect Dis. 2011;204:1960 1970. doi: 10.1093/infdis/jir666. 31. QueYA, Moreillon P. Infective endocarditis. Nat Rev Cardiol. 2011;8:322 336. doi: 10.1038/nrcardio.2011.43. 32. Patti JM, Allen BL, McGavin MJ, H k M. MSCRAMM-mediated adherence of microorganisms to host tissues. Annu Rev Microbiol. 1994;48:585 617. doi: 10.1146/annurev.mi.48.100194.003101. 33. Kitten T, Munro CL, Wang A, Macrina FL. Vaccination with FimA from Streptococcus parasanguis protects rats from endocarditis caused by other viridans streptococci. Infect Immun. 2002;70:422 425. Reviewer Disclosures Reviewer Employment Research Grant Other Research Support Speakers Bureau/Honoraria Expert Witness Ownership Interest Consultant/ Advisory Board Other Robert Campbell Sibley Heart Center Cardiology None None None None None None None Jeffrey Starke Baylor College of Medicine None None None None None None None This table represents the relationships of reviewers that may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure Questionnaire, which all reviewers are required to complete and submit. A relationship is considered to be significant if (a) the person receives $10000 or more during any 12-month period, or 5% or more of the person s gross income; or (b) the person owns 5% or more of the voting stock or share of the entity, or owns $10000 or more of the fair market value of the entity. A relationship is considered to be modest if it is less than significant under the preceding definition. 34. Donlan RM. Biofilm formation: a clinically relevant microbiological pro- cess. Clin Infect Dis. 2001;33:1387 1392. doi: 10.1086/322972. 35. 